Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 41 (HMGB1P41) is a pseudogene in Homo sapiens. Pseudogenes are genomic elements that closely resemble functional genes but contain disabling mutations or lack regulatory elements, and therefore do not produce functional proteins. HMGB1P41 shares sequence similarity with the coding gene HMGB1 but is noncoding and has no known biological function or direct disease relevance. It is not considered a therapeutic target[1][4]. As a pseudogene, HMGB1P41 is not an active protein or receptor and does not serve as a direct target for drugs or therapeutic intervention[1][4]. It is a pseudogene, which means it is not a functional gene product or a classical drug target in biomedical research or therapy. Listing it as a therapeutic target or receptor is incorrect[1][2]. As a pseudogene, HMGB1P41 falls into the "Other" molecular classification; it is not a transcription factor, receptor, enzyme, transporter, or ion channel[2][3]. It has no described roles in signal transduction, cell cycle, apoptosis, immune response, disease, or as a drug biomarker. Its parent gene, HMGB1, encodes a functional protein involved in DNA binding and chromatin organization, but HMGB1P41 itself is non-functional[1][4]. In summary, HMGB1P41 is a non-functional pseudogene, not a therapeutic target, with no clinical, biological, or mechanistic drug relevance based on current literature and gene annotation databases[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 41 (HMGB1P41).